Caudill Cortney bought HALO

March 10, 2026 · Form 4 insider transaction

Caudill Cortney bought 1,546 shares of Halozyme Therapeutics, Inc. at $33.51 per share, a transaction worth $51.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.